Federal Government
-
Federal Government Announces Blueprint Neurotherapeutics Network: Biologic-Based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Grant Funding
RFP | March 12, 2021 -
Federal Government Announces AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) Grant Funding
RFP | March 5, 2021 -
Federal Government Announces Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces Early Stage Testing of Pharmacologic or Device-Based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) Grant Funding
RFP | March 3, 2021 -
Federal Government Announces Strategic Prevention Framework for Prescription Drugs Grant Funding
RFP | March 2, 2021 -
Federal Government Announces Midlife in the U.S. Study – Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed) Grant Funding
RFP | March 1, 2021 -
Federal Government Announces Medication Assisted Treatment – Prescription Drug and Opioid Addiction Grant Funding
RFP | March 1, 2021 -
Vaccine Hesitancy Falls In Priority Groups, But Only Half Of Adults Under 65 Willing
Weekly News Wire | February 24, 2021 -
Federal Government Announces Section 202 Supportive Housing for the Elderly Program Grant Funding
RFP | February 24, 2021 -
COVID-19 Vaccination Intent, Perceptions & Reasons For Not Vaccinating Among Groups Prioritized For Early Vaccination — United States, September & December 2020
Market Intelligence Resource | February 23, 2021 -
Executive Order On Strengthening Medicaid & The Affordable Care Act
Market Intelligence Resource | February 23, 2021 -
Federal Government Announces Drug Development Tools Research Grants (U01) Clinical Trial Optional Funding
RFP | February 19, 2021 -
Federal Government Announces Provider’s Clinical Support System – Universities Grant Funding
RFP | February 19, 2021 -
Federal Government Announces Screening, Brief Intervention, and Referral to Treatment Grant Funding
RFP | February 18, 2021 -
Federal Government Announces NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Grant Funding
RFP | February 11, 2021 -
Federal Government Announces NEI Translational Research Program on Therapy for Visual Disorders (R24 Clinical Trial Optional) Grant Funding
RFP | February 10, 2021 -
FDA Launches Digital Health Center Of Excellence
Market Watch | February 9, 2021 -
Executive Order On Reforming Our Incarceration System To Eliminate The Use Of Privately Operated Criminal Detention Facilities
Market Intelligence Resource | February 9, 2021 -
Child Maltreatment 2019
Market Intelligence Resource | February 9, 2021 -
Cannabidiol & Other Cannabinoids: Sex & Gender Differences in Use & Responses; Public Meeting
Market Intelligence Resource | February 9, 2021 -
Federal Government Announces Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) Grant Funding
RFP | February 8, 2021